⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AMGN News

Amgen Inc

REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C